This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Katsanos K, Geisler BP, Garner AM, et al. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK. BMJ Open. 2016;6: e011245. https://doi.org/10.1136/bmjopen-2016-011245.
Gemeinhardt O, Haase T, Schnorr B, Xie J, Löchel M, Schütt D, Mittag A, Haider W, Bettink S, Speck U, Tepe G, Improvement of outcome for treatment of 'restenosis-prone' vascular lesions? Potential impact of the paclitaxel dose on late lumen loss in porcine peripheral arteries. Cardiovasc Intervent Radiol. 2022;15 Sep 2022. https://doi.org/10.1007/s00270-022-03277-x. Online ahead of print
Ruebben A, Boeing J, Weiss N. Drug-eluting balloon analysis. Interv Cardiol. 2011;6(1):56–7.
Liistro F, Di Mario C. Paclitaxel-coated balloons in peripheral artery disease: How much is enough? Eur Heart J. 2020;41(27):2553–5.
This study/article was not supported by any funding.
Conflict of interest
The author declares that he has no conflict of interest.
Human and Animal Participants
This article does not contain any studies with human participants or animals performed by any of the authors. Institutional review board (IRB) approval was not required for this article.
For this type of study/article, informed consent is not required.
Consent for Publication
For this type of study/article, consent for publication is not required.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cleveland, T. Commentary: Improvement of Outcome for Treatment of “Restenosis-Prone” Vascular Lesions? Potential Impact of the Paclitaxel Dose on Late Lumen Loss in Porcine Peripheral Arteries. Cardiovasc Intervent Radiol 45, 1832–1833 (2022). https://doi.org/10.1007/s00270-022-03299-5